News Channels

25 Jul 2019 Proteostasis Therapeutics Initiates Dosing in Global Phase 2 Study in Cystic Fibrosis
25 Jul 2019 Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome
25 Jul 2019 Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227
25 Jul 2019 Bristol-Myers Squibb Announces CheckMate -227 Part 1a Meets Co-Primary Endpoint of Overall Survival
25 Jul 2019 Epizyme Announces FDA Filing Acceptance of New Drug Application and Priority Review for Tazemetostat for the Treatment of Epithelioid Sarcoma
24 Jul 2019 Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
24 Jul 2019 Merck Announces Presentation of Phase 2b Results for Investigational HIV-1 Therapy Islatravir (MK-8591) at IAS 2019
24 Jul 2019 ViiV Healthcare presents GEMINI 1 & 2 studies through Week 96 showing 2-drug regimen of dolutegravir plus lamivudine continues to demonstrate high efficacy rates and no cases of treatment emergent resistance
24 Jul 2019 Oyster Point Pharma Announces Enrollment of First Subject in Phase 3 Clinical Trial of Nasal Spray for Dry Eye Disease
24 Jul 2019 Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
24 Jul 2019 Gilead Announces Latest Data in Ongoing HIV Cure Research Program
24 Jul 2019 Ligand Acquires Ab Initio Biotherapeutics, an Antigen-Discovery Company
24 Jul 2019 FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
24 Jul 2019 FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions
23 Jul 2019 Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum Depression
23 Jul 2019 Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence Study
23 Jul 2019 Novel Drug Being Developed for HIV Prevention and Cancer Indications Demonstrates Best-in-Class Potency
23 Jul 2019 IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program
23 Jul 2019 Oncolytics Biotech(R) Announces Preliminary AWARE-1 Trial Data Demonstrating Viral Replication and Promotion of Inflammation Following Systemic Administration of Pelareorep When Combined with Tecentriq(R)
23 Jul 2019 Merck Presents Early Evidence on Extended Delivery of Investigational Anti-HIV-1 Agent Islatravir (MK-8591) via Subdermal Implant

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up